Fractional CO2 laser therapy for genitourinary syndrome of menopause for breast cancer survivorsAllison Quick, Maryam B. Lustberg, Filadelfiya Zvinovski et al.|Supportive Care in Cancer|2019Cited by 43
A phase I study of an oral selective gamma secretase (GS) inhibitor RO4929097 in combination with neoadjuvant paclitaxel and carboplatin in triple negative breast cancerSagar Sardesai, Robert Wesolowski, Mitch A. Phelps et al.|Investigational New Drugs|2020Cited by 37
Clinical impact of interruption in adjuvant Trastuzumab therapy in patients with operable HER-2 positive breast cancerSagar Sardesai, Bhuvaneswari Ramaswamy, Jasmine Sukumar et al.|Cardio-Oncology|2020Cited by 32
Assessment of outcomes and novel immune biomarkers in metaplastic breast cancer: a single institution retrospective studyEvan Morgan, Maryam B. Lustberg, Anupama Suresh et al.|World Journal of Surgical Oncology|2020Cited by 31
Patient-reported sexual function of breast cancer survivors with genitourinary syndrome of menopause after fractional CO2 laser therapyAllison Quick, Maryam B. Lustberg, Filadelfiya Zvinovski et al.|Menopause The Journal of The North American Menopause Society|2021Cited by 29